# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants

> **NCT07521748** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Nanjing Reju Therapeutics Co., Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** RC017 Ophthalmic Ointment
- **DRUG:** RC017 Ophthalmic Ointment placebo

## Key facts

- **NCT ID:** NCT07521748
- **Lead sponsor:** Nanjing Reju Therapeutics Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07521748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07521748, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07521748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*